🇺🇸 FDA
Patent

US 11014895

Heterocyclic urea compound, and drug composition and application thereof

granted A61PA61P35/00A61P35/02

Quick answer

US patent 11014895 (Heterocyclic urea compound, and drug composition and application thereof) held by CHINA PHARMACEUTICAL UNIVERSITY expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CHINA PHARMACEUTICAL UNIVERSITY
Grant date
Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P35/00, A61P35/02